HSase treatment reduced more than 72% SARS-Cov-2 pseudovirus entry into 293T-ACE2 cells, showing that binding of SV2-S to cell surface HS plays a key role in mediating the virus infection of host cells (Figure 4A). The gene discussed is ACE2; the disease is viral infectious disease.